• 1
    Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266: 1865-9.
  • 2
    Roizman B. New viral footprints in Kaposi's sarcoma. N Engl J Med 1995; 332: 1227-8.
  • 3
    Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma- associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995; 332: 1186-91.
  • 4
    Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. N Engl J Med 1995; 332: 1181-5.
  • 5
    Huang YQ, Li JJ, Kaplan MH, Poiesz B, Katabira E, Zhang WC, et al. Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma. Lancet 1995; 345: 759-61.
  • 6
    Dupin N, Grandadam M, Calvez V, Gorin I, Aubin JT, Havard S, et al. Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma. Lancet 1995; 345: 761-2.
  • 7
    Schalling M, Ekman M, Kaaya EE, Linde A, Biberfeld P. A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma. Nat Med 1995; 1: 707-8.
  • 8
    Boshoff C, Whitby D, Hatziioannou T, Fisher C, van der Walt J, Hatzakis A, et al. Kaposi's sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma. Lancet 1995; 345: 1043-4.
  • 9
    Ambroziak JA, Blackbourn DJ, Herndier BG, Glogau RG, Gullett JH, McDonald AR, et al. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. Science 1995; 268: 582-3.
  • 10
    Pastore C, Gloghini A, Volpe G, Nomdedeu J, Leonardo E, Mazza U, et al. Distribution of Kaposi's sarcoma herpesvirus sequences among lymphoid malignancies in Italy and Spain. Br J Haematol 1995; 91: 918-20.
  • 11
    Otsuki T, Kumar S, Ensoli B, Kingma DW, Yano T, Stetler-Stevenson M, et al. Detection of HHV-8/KSHV DNA sequences in AIDS-associated extranodal lymphoid malignancies. Leukemia 1996; 10: 1358-62.
  • 12
    Karcher DS, Alkan S. Herpes-like DNA sequences, AIDS-related tumors and Castleman's disease. N Engl J Med 1995; 333: 797-8.
  • 13
    Dupin N, Gorin I, Deleuze J, Agut H, Huraux JM, Escande JP. Herpes-like DNA sequences, AIDS-related tumors and Castleman's disease. N Engl J Med 1995; 333: 798.
  • 14
    Wynia MK, Shapiro B, Kuvin JT, Skolnik PR. Fatal Castleman's disease and pulmonary Kaposi's sarcoma in an HIV-seropositive woman. AIDS 1995; 9: 814-6.
  • 15
    Gessain A, Sudaka A, Briere J, Fouchard N, Nicola MA, Rio B, et al. Kaposi's sarcoma-associated herpes-like virus (human herpesvirus type 8) DNA sequences in multicentric Castleman's disease: is there any relevant association in non-human immunodeficiency virus-infected patients? Blood 1996; 87: 414-6.
  • 16
    Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995; 86: 1276-80.
  • 17
    Luppi M, Barozzi P, Maiorana A, Artusi T, Trovato R, Marasca R, et al. Human herpesvirus-8 DNA sequences in human immunodeficiency virus-negative angioimmunoblastic lymphadenopathy and benign lymphadenopathy with giant germinal center hyperplasia and increased vascularity. Blood 1996; 87: 3903-9.
  • 18
    Bigoni B, Dolcetti R, de Lellis L, Carbone A, Boiocchi M, Cassai E, et al. Human herpesvirus 8 is present in the lymphoid system of healthy persons and can reactivate in the course of AIDS. J Infect Dis 1996; 173: 542-9.
  • 19
    Monini P, de Lellis L, Fabris M, Rigolin F, Cassai E. Kaposi's sarcoma-associated herpesvirus DNA sequences in prostate tissue and human semen. N Engl J Med 1996; 334: 1168-72.
  • 20
    Whitby D, Howard MR, Tenant-Flowers M, Brink NS, Copas A, Boshoff C, et al. Detection of Kaposi's sarcoma-associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 1995; 346: 799-803.
  • 21
    Moore PS, Kingsley LA, Holmberg SD, Spira T, Gupta P, Hoover DR, et al. Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma. AIDS 1996; 10: 175-80.
  • 22
    Shingadia D, Howard MR, Brink NS, Gibb D, Klein N, Tedder R, et al. Kaposi's sarcoma and KSHV. Lancet 1995; 346: 1359-60.
  • 23
    Maniatis T, Fritsch EF, Sambrook J. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1982.
  • 24
    Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
  • 25
    Wright DK, Manos MM. Sample preparation from paraffin-embedded tissues. In: InnisMA, GelfandDH, SninskyJF, WhiteTF. PCR protocols: a guide to methods and applications. San Diego, CA: Academic Press, 1990: 1538.
  • 26
    Cesarman E, Nador RG, Bai F, Bohenzky RA, Russo JJ, Moore PS, et al. Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma. J Virol 1996; 70: 8218-23.
  • 27
    Lin JC, Lin SC, De BK, Chan WP, Evatt BL. Precision of genotyping of Epstein-Barr virus by polymerase chain reaction using three gene loci (EBNA-2, EBNA-3C, and EBER): predominance of type A virus associated with Hodgkin's disease. Blood 1993; 81: 3372-81.
  • 28
    Ou CY, Kwok S, Mitchell SW, Mack DH, Sninsky JJ, Krebs JW, et al. DNA amplification for direct detection of HIV-1 DNA of peripheral blood mononuclear cells cells. Science 1988; 239: 295-7.
  • 29
    Frank D, Cesarman E, Liu YF, Michler RE, Knowles DM. Posttransplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus. Blood 1995; 85: 1396-403.
  • 30
    Gao SJ, Kingsley L, Li M, Zheng W, Parravicini C, Ziegler J, et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 1996; 2: 925-8.
  • 31
    Frizzera G, Peterson BA, Bayrd ED, Goldman A. A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol 1985; 3: 1202-16.
  • 32
    Frizzera G. Atypical lymphoproliferative disorders. In: KnowlesDM. Neoplastic Hematopathology. Baltimore, MD: Williams and Wilkins, 1992: 45995.
  • 33
    Menke DM, Camoriano JK, Banks PM. Angiofollicular lymph node hyperplasia: a comparison of unicentric, multicentric, hyaline vascular, and plasma cell types of disease by morphometric and clinical analysis. Mod Pathol 1992; 5: 525-30.
  • 34
    Peterson BA, Frizzera G. Multicentric Castleman's disease. Semin Oncol 1993; 20: 636-47.
  • 35
    Frizzera G. :Castleman's disease: more questions than answers. Hum Pathol 1985; 16: 202-5.
  • 36
    Francis ND, Hollowood K, Gabriel R. Angiofollicular lymph node hyperplasia. J Clin Pathol 1988; 41: 353-6.
  • 37
    Isaacson PG. Castleman's disease [commentary]. Histopathology 1989; 14: 429-32.
  • 38
    Harris NL. Hypervascular follicular hyperplasia and Kaposi's sarcoma in patients at risk for AIDS. N Engl J Med 1984; 310: 462-3.
  • 39
    Lachant NA, Sun NCJ, Leong LA, Oseas RS, Prince HE. Multicentric angiofollicular lymph node hyperplasia (Castleman's disease) followed by Kaposi's sarcoma in two homosexual males with the acquired immunodeficiency syndrome (AIDS). Am J Clin Pathol 1985; 83: 27-33.
  • 40
    Chadburn A, Metroka C, Mouradian J. Progressive lymph node histology and its prognostic value in patients with acquired imunodeficiencey syndrome and AIDS-related complex. Hum Pathol 1989; 20: 579-87.
  • 41
    Knowles DM, Chadburn A. Lymphadenopathy and the lymphoid neoplasms associated with the acquired immune deficiency syndrome (AIDS). In: KnowlesDM. Neoplastic Hematopathology. Baltimore, MD: Williams and Wilkins, 1992: 773835.
  • 42
    Menke DM, Tiemann M, Camoriano JK, Chang SF, Madan A, Chow M, et al. Diagnosis of Castleman's disease by identification of an immunophenotypically aberrant population of mantle zone B lymphocytes in paraffin-embedded lymph node biopsies. Am J Clin Pathol 1996; 105: 268-76.
  • 43
    Hall PA, Donaghy M, Cotter FE, Stansfeld AG, Levison DA. An immunohistological and genotypic study of plasma cell form of Castleman's disease. Histopathology 1989; 14: 333-46.
  • 44
    Kasaian MT, Ikematsu H, Casali P. Identification and analysis of a novel human surface CD5- B lymphocyte subset producing natural antibodies. J Immunol 1992; 148: 2690-702.
  • 45
    Taki S, Schmitt M, Tarlinton D, Forster I, Rajewsky K. T cell-dependent antibody production by Ly-1 B cells. Ann N Y Acad Sci 1992; 651: 328-35.
  • 46
    Haran-Ghera N, Peled A, Brightman BK, Fan H. Lymphomagenesis in AKR.FV-1b congenic mice. Cancer Res 1993; 53: 3433-8.
  • 47
    van den Oord JJ, de Wolf-Peeters C, Tricot G, Desmet VJ. Distribution of lymphocyte subsets in a case of angiofollicular lymph node hyperplasia. Am J Clin Pathol 1984; 82: 491-5.
  • 48
    Yabuhara A, Yanagisawa M, Murata T, Kawai H, Komiyama A, Akabane T, et al. Giant lymph node hyperplasia (Castleman's disease) with spontaneous production of high levels of B-cell differentiation factor activity. Cancer 1989; 63: 260-5.
  • 49
    Yoshizaki K, Matsuda T, Nishimoto N, Kuritani T, Taeho L, Aozasa K, et al. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 1989; 74: 1360-7.
  • 50
    Lennette ET, Blackbourn DJ, Levy JA. Antibodies to human herpesvirus type 8 in the general population and Kaposi's sarcoma patients. Lancet 1996; 348: 858-61.